Index Industries Raises $50 Million in Funding to Reinvent How the World Invests in Real Estate

  • Index Industries is co-founded by Josh Rosenthal, formerly the President of Polychain Capital, joining as CEO, and Brian Hardecker, CEO of Longmark and formerly of Blackstone, joining as Chairman.
  • The round is backed by Lightspeed Venture Partners, Galaxy Ventures, Polychain Capital, Wintermute Ventures and more.
  • Index Industries will launch the USHP Index, a proprietary benchmark for U.S. home prices, made investable through USHP, a liquid index product, issued by USHP Limited.

NEW YORK, Nov. 10, 2026 — Index Industries emerges from stealth with a $50 million seed round led by Lightspeed Venture Partners, with participation from Polychain Capital, Galaxy Ventures, Wintermute Ventures, and other institutional investors. The company is building the technology and infrastructure to transform U.S. housing into a broadly investable asset class. Its platform combines a daily-reporting index with tokenization technology and real estate and capital markets services to power third-party housing-linked investment products. USHP, based on Index Industries’ U.S. Home Price Index and issued by USHP Limited (BVI), will be the first investment product built on the platform.

U.S. housing is a $55 trillion market, making it one of the largest asset classes in the U.S. Yet despite its scale, broad-based investment exposure to U.S. home prices has remained difficult to access through traditional financial products. Index Industries was founded to close that gap.

Index Industries’ first offering will be the U.S. Home Price Index (USHP Index), a proprietary benchmark for U.S. home prices. Calculated daily, it integrates data from the major housing indices into a single national measure, providing a continuous and comprehensive read on home prices. The index is intended to support housing-market research, reporting, and portfolio monitoring and housing-related financial products.

Index Industries is co-founded by Josh Rosenthal, who joins as CEO following his role as President and General Partner of Polychain Capital, and Brian Hardecker, a former Principal at Blackstone and the Founder and CEO of Longmark, a leading residential real estate platform formed in 2021 that has $2 billion in assets under management. Index Industries combines two worlds of expertise to bring breakthrough tokenization technology to new real estate assets.

“Indexing is one of the most important and least celebrated innovations in modern finance. It reduces the expertise and cost barriers to investing in an entire market, which is what U.S. housing needs,” said Josh Rosenthal, co-founder & CEO of Index Industries. “I’ve spent my career looking for industry-shaping financial technology, and Index Industries is exactly that. It has the potential to change how the world sees housing: not just as a roof over your head or something that is out of reach, but as an investable asset class.”

“U.S. housing is a massive market. It accounts for roughly a quarter of the aggregate value of the U.S. economy, yet it draws far less attention because there haven’t been accessible ways to take a position in it,” said Brian Hardecker, co-founder and chairman of Index Industries and CEO of Longmark Group. “Housing is uniquely inflation-protected, uncorrelated to other asset classes, and has arguably been one of the most stable paths to wealth accumulation. It hasn’t seen the benefits of financial innovation that other sectors have. That’s beginning to change with USHP, and we’re proud to play a role.”

“Real estate is one of tokenization‘s biggest opportunities, but bringing a $55 trillion asset class onchain requires traditional institutional infrastructure no crypto-native team has ever had. That’s the gap Index Industries closes. It’s rare to see two worlds of expertise converge at this caliber: traditional institutional rigor paired with scalable, secure, compliant technology that will unlock access and liquidity for the world’s largest asset class. Index Industries’ partnership with Longmark made leading this investment an easy decision for Lightspeed,” said Justin Overdorff, Partner at Lightspeed Venture Partners.

Tokenization is a defining innovation in financial markets today, and the world’s largest institutions are racing to adopt it. Index Industries applies tokenization to one of the most sought-after asset classes and is designed to create entirely new financial products that unlock access, income, and liquidity at institutional scale.

The USHP Index is expected to launch imminently. USHP Limited plans to release USHP in 2026 on Ethereum and expand to Solana in 2027. For more information, visit indexindustries.com.

About Index Industries

Index Industries is building the technology and infrastructure to transform U.S. housing into a broadly investable asset class. Founded in 2026 by Josh Rosenthal, CEO of Index Industries and former President of Polychain, and Brian Hardecker, Chairman of Index Industries and CEO of Longmark Group, formerly of Blackstone Real Estate, Index Industries manages the U.S. Home Price Index and provides technology for USHP. To learn more, visit indexindustries.com and follow us on X at @index_inds.

Media Contact: [email protected]

Important Notice

This press release is for informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy, any securities or other financial instrument in any jurisdiction, including the United States, or to or for the account or benefit of any U.S. person. No securities described or referenced herein have been or will be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state of the United States, and no such securities may be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from registration. Index Industries is not the issuer of USHP and will not offer, sell, distribute, market, redeem, or accept subscriptions for USHP. USHP is expected to be issued by USHP Limited, a British Virgin Islands company and a subsidiary of the USHP Foundation, a Cayman Islands foundation company. Any offering of USHP, if made, will be made solely by the issuer pursuant to separate offering materials and only to eligible non-U.S. persons outside the United States in accordance with applicable law.

SOURCE Index Industries


Labelbox partners with Wipro to scale adoption of AI agents that learn from enterprise experience

Wipro Ventures participated in Labelbox’s recent Series E funding round

SAN FRANCISCO, Nov. 10, 2026 — Labelbox, the leading data factory trusted by top AI labs and enterprises, has announced its strategic partnership with Wipro Limited, a global AI-powered technology services and consulting company, to accelerate the deployment of AI agents across complex enterprise operations. The partnership brings together Labelbox’s AI capabilities with Wipro’s global expertise and delivery scale to enhance adoption of production-ready AI systems that learn from enterprise experience. Wipro Ventures, the corporate investment arm of Wipro, also announced its participation in Labelbox’s recent funding round.

“Building frontier AI requires bringing exceptional domain expertise closer to the teams developing and deploying AI systems,” said Manu Sharma, CEO of Labelbox. “Through our partnership with Wipro, we look forward to helping enterprises turn their knowledge, workflows, and standards into AI systems that can be rigorously evaluated, continuously improved, and deployed responsibly at scale. Together, we aim to accelerate the adoption of AI agents that learn from experience and deliver meaningful, measurable outcomes across complex enterprise operations.”

The collaboration will integrate Labelbox’s reinforcement learning capabilities with Wipro Intelligence™, the unified suite of AI-powered platforms, solutions, and transformative offerings. Wipro’s forward-deployed engineers (FDEs) will support workflow selection, systems integration, domain-expertise capture, and performance measurement, while customers retain control over permissions, standards, and sensitive actions. Initial use cases include identifying data-quality issues, rerunning evaluations when models change, and comparing experiments to recommend the next step.

“As enterprises move towards more advanced AI systems, reinforcement learning will play an increasingly important role in developing models capable of addressing complex, real-world challenges,” said Malay Joshi, CEO of Americas 1, Wipro Limited. “By bringing Labelbox’s reinforcement learning capabilities with Wipro Intelligence™, and pairing them with our FDEs, we are giving clients a faster, governed path from promising pilots to production results they can measure.”

Labelbox combines managed enterprise agents with reinforcement learning environments and evaluations in a single platform. Unlike a standalone model, its technology is designed around an organization’s own workflows, systems, knowledge, and standards. Labelbox’s Recursion enables agents to coordinate work across business applications, show the evidence behind each result, and retain lessons from reviewed work. Its Horizon product provides reinforcement learning environments and evaluations for reasoning, coding, tool use, and computer use. Together, these capabilities create a feedback loop in which AI systems can be tested, governed, and improved through experience.

About Labelbox
Labelbox is the leading data factory for frontier model development. Trusted by over 80% of leading AI labs in the US and hundreds of enterprises worldwide, Labelbox provides integrated software, managed services, and an expert network that enable organizations to create the high-quality training data required for breakthrough AI systems. Headquartered in San Francisco, the company is backed by leading investors including SoftBank, Andreessen Horowitz, B Capital, Gradient Ventures, Databricks Ventures, and Kleiner Perkins.

SOURCE Labelbox

Nidus Raises $30M to Deploy Embodied Intelligence in America’s Defense Factories

Backed by Kleiner Perkins and Costanoa, Nidus brings intelligent, autonomous systems that dramatically increase factory output, beginning with the wire harnesses inside every aircraft, missile, and vehicle

NEW YORK, Nov. 10, 2026 — Nidus, the robotics company deploying embodied intelligence inside America’s defense factories, announced $30 million in funding today, backed by Kleiner Perkins and Costanoa, with participation from Ludlow Ventures, SF1, Absolute Partners, Tau, and angel investors, including Chris Power, founder of Hadrian; Adrian Aoun, co-founder of Dulo, Foundational Industries and Seneca; and Nikhil Goel, Chief Commercial Officer at Archer.

America’s defense industrial base has a capacity crisis. The country that once produced more than half the world’s goods now relies heavily on overseas supply chains to manufacture parts for its own weapons systems. This constitutes a national security risk, and factories urgently need to increase output to meet demand.

Nidus builds embodied intelligence that lets traditional industrial robots perform precision assembly tasks. The company develops and deploys foundation robotics models across America’s critical defense factories, using sovereign AI training practices. This lets each customer retain its collective knowledge, which is crucial in secure environments.

“I grew up in rural South Carolina and watched offshoring create the current industrial base crisis,” said Justin Sealy, co-founder and CEO of Nidus. “At this point, we can’t out-labor or out-scale our competition. We need to leapfrog the rest of the world by deploying physical AI that scales America’s existing industrial capacity. This is why we started Nidus.”

Nidus is deploying across the defense industrial base and quickly eclipsed seven figures in revenue in its first four months. The company is currently delivering customized models to automate wire processing on its proprietary platform, which was built from the ground up to meet Department of War security requirements.

“In physical AI, the value will accrue to players that prioritize deployment and customer value. And Nidus is the rare team that has actually deployed AI into the most locked-down environments in the country” said Aatish Nayak, partner at Kleiner Perkins. “The demand they’re seeing is a testament to the value of their mission and product. We’re thrilled to back Justin, Charu, Harrison, and Cane as they bring AI to the factories America’s security depends on.”

“The U.S. cannot rebuild industrial capacity through new construction alone. Nidus is taking a different approach, using AI and robotics to increase production inside existing factories,” said Greg Sands, Founder and Managing Partner at Costanoa. “We backed Justin and the team at pre-seed because of their firsthand experience with the challenges of American manufacturing and their technical ability to address them. We believe Nidus has the potential to make a meaningful difference in how critical products are manufactured in the U.S.”

Nidus will use this funding to grow its engineering team, expand from wire-harness automation into additional factory workflows, and scale production deployments with U.S. defense manufacturers.

“We only build for American institutions that are vital for securing democracy,” added Sealy. “We believe in a future where American industry is self-sustaining and no longer dependent on foreign production. We’re building the infrastructure to make that future a reality.”

About Nidus

Nidus is the leading developer of industrial AI, purpose-built to augment America’s manufacturing base. We are on a mission to equip the factories that enable American industry with embodied intelligence that radically scales operations. Founded by a team with decades of experience across machine learning, robotics, hardware, and defense tech, Nidus brings foundation models out of the lab and onto the factory floor. Learn more at nidus.tech.

Media contact: [email protected]

SOURCE Nidus Technologies

SPARETECH raises $20M Series B to help manufacturers cut industrial spare parts inventory by 60%

SPARETECH aims to cut manufacturers’ spare parts inventory by 60% within three years with AI that ensures parts are available when they are needed

MUNICH, Nov. 10, 2026 — SPARETECH, a provider of enterprise AI for spare parts management, today announced it has raised $20 million in Series B funding to help manufacturers cut their spare parts inventory without risking downtime. Blume Equity and Insight Partners co-led the round, with participation from Headline.

Geographic expansion and growth trajectory

SPARETECH has established itself in the United States and grown its revenue fivefold since the start of 2024. Over the same period, the company grew its spare parts catalog to more than 40 million verified parts and expanded its network to 15,000 manufacturer and supplier partners. The global rollout of Nestlé, a SPARETECH customer, put 320 plants across 70 countries live in less than a year, further affirming SPARETECH’s global enterprise capabilities and speed.

“Every customer we work with wants the same thing: the production line running with less inventory on the shelf. That is the problem we are going to solve with Maintenance teams, and our goal is to cut spare parts inventory by 60% in the next three years, while securing the same uptime.”
Martin Weber, CEO and Co-Founder, SPARETECH

Why spare parts stay on the shelf

Spare parts management has long been one of manufacturing’s most persistent inefficiencies. A single stockout can halt production and idle an entire line, making plants default to holding extensive spare parts inventories as a safeguard. The result is a substantial amount of capital sitting on the shelf. SPARETECH’s 2026 benchmark report puts the average value of spare parts inventory at $169 million per company.

Source: Unlocking cost savings in spare parts management: The 2026 benchmark report on MRO spend, productivity, and working capital, SPARETECH, 2026.

From visibility to availability

Since its founding, SPARETECH has helped customers gain visibility into the parts they hold and standardize their spare parts data, which is the foundation of effective spare parts management. Meaningfully reducing inventory levels, however, requires more than good data. It requires physical action.

SPARETECH is moving the market beyond insights and recommendations toward measurable outcomes: lower inventory with the same uptime. To reach the 60% goal, every maintenance professional needs confidence that the right part will be available when needed, even if it sits on another company’s shelf. SPARETECH’s AI will secure that availability.

“Every part sitting idle is cash that could be working somewhere else. We are building AI that makes sure the right part is available when a plant needs it and put those idle parts back into circulation, so the money tied up on the shelf can go back to growing the business.”
Dr. Lukas Biedermann, COO and Co-Founder, SPARETECH

Why now

Industrial automation keeps expanding, and a single new production line can add thousands of spare parts that someone has to stock. The problem grows with every machine that is installed. With the cost of capital rising, manufacturers can no longer afford to keep that much money sitting on the shelf. At the same time, AI can now secure availability at a scale no team could manage by hand.

“Often building resilience in supply chain ends up in building more inventories for spare parts. A much more suitable way would be a system, which secures better resilience with up to 60% less inventories sitting on the shelves. SPARETECH is exactly doing this. A fascinating opportunity especially for the manufacturing industry.”
Joe Kaeser,
Chairman of the Supervisory Board of Siemens Energy and Daimler Truck 

“SPARETECH is exactly the kind of business we back. Idle spare parts are a large, overlooked pool of wasted resources, and putting them back to work gives manufacturers a measurable return and the planet less waste. We are delighted to partner with Martin, Lukas, and the team as they scale.”
Michelle Capiod,
Co-Founding Partner, Blume Equity

Investing in innovation and expansion

SPARETECH will use the funding to continue building the AI that secures spare part availability for industrial companies and put their surplus parts back into circulation, expand its presence in North America and new regions, and deepen its work with existing customers.

“The next stage of SPARETECH’s growth runs through North America. American manufacturers operate large plant networks with a lot of capital tied up in spare parts, and they need a partner built for that scale. Insight has spent decades helping software companies grow in the United States, and we are excited to support Martin, Lukas, and the team as they scale.”
Brad Fiedler, Managing Director, Insight Partners

“The digital world is moving into the physical one, and Germany has the industrial substance to lead that shift. SPARETECH is building industrial AI for spare parts management, and it already gives maintenance and procurement teams confidence in uncertain times. This is where industrial AI starts to pay off for global manufacturers.”
Christian Miele, General Partner, Headline

Learn more at sparetech.io.

About SPARETECH

SPARETECH’s enterprise AI software empowers global manufacturers to reduce their spare parts spend and inventory. Built on verified original manufacturer data, the platform standardizes material master data, right-sizes inventory across plants, and enables sourcing and surplus resale across the network. Maintenance and procurement teams know what they have, get what they need, and sell what they don’t.

Trusted by manufacturers like Nestlé, Porsche, VW, Bosch, and Sanofi, the company is moving toward its vision of a zero-waste industrial sharing economy.

About Blume Equity

Blume Equity is a European growth equity firm based in London and Amsterdam, backing technology companies that build cleaner energy systems, smarter industry and more climate-resilient economies. Its team works closely with founders to help businesses scale and create long-term value.

For more information, visit blumeequity.com.

About Insight Partners

Insight Partners is a global AI and software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of June 30, 2026, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 900 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow on X @insightpartners.

About Headline

Headline is a venture capital firm that partners with exceptional technology teams with global ambitions. The firm manages more than $5 billion in assets and invests through regionally focused early-stage funds across the US, Europe, Asia, and Latin America, as well as Headline Growth, which invests worldwide from Series B to the public market. Headline is headquartered in San Francisco and has eight global offices. Learn more at headline.com.

Media contact:
Charles Mackenzie
VP Marketing, SPARETECH
[email protected] 

EnVision Endoscopy Announces Oversubscribed Series A Financing and Reaches First 50 Patient Procedures with SimpleStitch™ Suturing System

WALTHAM, Mass., Nov. 10, 2026 — EnVision Endoscopy, Inc., a medical technology company developing innovative solutions for gastrointestinal (GI) endoscopic surgery, today announced the successful closing of an oversubscribed $11.5 million Series A financing and the completion of its first 50 patient procedures using the SimpleStitch™ Suturing System.

Together, these milestones mark a significant step in the company’s transition from technology development to clinical adoption and commercial expansion, supporting its mission to make endoscopic suturing more accessible to physicians performing minimally invasive gastrointestinal procedures.

Designed for use with standard flexible endoscopes, the SimpleStitch™ Suturing System is intended to help physicians with an intuitive approach and easy-to-use technology to perform endoscopic suturing. The technology is designed to address longstanding challenges associated with tissue closure following advanced gastrointestinal endoscopic procedures, potentially expanding access to suturing beyond specialized expert centers.

EnVision received FDA clearance for the SimpleStitch™ Suturing System in 2025 and initiated a limited U.S. market release in 2026. The completion of the first 50 patient procedures represents an important milestone in building clinical experience, strengthening physician partnerships, and advancing the company’s commercial strategy.

“Technologies to simplify endoscopic resection are coming, and closure should be even simpler. SimpleStitch™ bridges the gap between conventional clips and advanced endoscopic suturing, making strong, confident tissue closure more accessible. I’m excited that 50 procedures have now been safely completed at pilot sites in 2026. This is an important step toward bringing better closure options to physicians and their patients,” said Dr. Andrew Storm of Atrium Health Wake Forest Baptist, who performed the first-in-human procedure with SimpleStitch™.

“We founded EnVision to address persistent challenges in endoscopic surgery. Reaching our first 50 patient procedures validates the work of our team and physician collaborators in bringing SimpleStitch™ into clinical practice. Combined with our Series A financing, this milestone positions us to build on that momentum and bring our technology to more physicians and patients,” said Azadeh Khanicheh, Ph.D., Co-Founder and Chief Executive Officer of EnVision Endoscopy.

Series A Financing to Support Commercial Expansion
The oversubscribed $11.5 million Series A financing was led by Puma Venture Capital, with participation from UTEC – University of Tokyo Edge Capital, existing investor Olympus Corporation of the Americas, and MassVentures.

“Puma backs minimally invasive technologies that can improve both labor productivity and how well patients do. SimpleStitch™ takes endoscopic suturing out of a handful of expert centers and puts it on the scope a physician already owns. More endoscopists can close with confidence, more patients get a less invasive option, and that’s why we led this round,” said Amit Hazan, Co-Founder and Managing Partner of Puma Venture Capital.

The financing will support EnVision Endoscopy’s next phase of growth, including expanded commercial availability, physician training, clinical evidence generation, manufacturing scale-up, and further product development.

The strong investor participation reflects confidence in EnVision Endoscopy’s technology, its approach to addressing unmet needs in gastrointestinal endoscopic surgery, and the growing opportunity to advance minimally invasive endoscopic interventions.

Addressing a Growing Need for Endoscopic Closure
Endoscopy is steadily replacing surgery for a growing range of gastrointestinal conditions. More than 20 million gastrointestinal endoscopic procedures are performed in the U.S. each year, and advanced resection techniques such as endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and peroral endoscopic myotomy (POEM) are being adopted rapidly in the U.S. and Europe. Each of these procedures can leave defects that need secure closure.

The endoscopic closure device market is projected to grow 7–8% annually through the end of the decade. Yet endoscopic suturing remains concentrated in a small number of expert centers, because existing systems require extensive training and dedicated equipment. SimpleStitch™ is designed to close this gap by bringing suturing to the broader community of endoscopists using the endoscopes they already have.

About EnVision Endoscopy, Inc.
EnVision Endoscopy, Inc. is a Waltham, Massachusetts-based medical technology company developing innovative devices for gastrointestinal endoscopic surgery. Co-founded by Azadeh Khanicheh, Ph.D., and Christopher C. Thompson, MD, MSc, the company is focused on addressing unmet clinical needs through technologies that support less invasive endoscopic procedures.

Its SimpleStitch™ Suturing System is designed to facilitate endoscopic suturing and tissue approximation using standard flexible endoscopes. EnVision’s mission is to advance endoscopic surgery through practical, innovative technologies that serve physicians and patients.

For more information, visit: www.envisionendoscopy.com

SOURCE ENVISION ENDOSCOPY INC.

Calibrant Energy Secures $145 Million in Project Financing, Including Battery Storage for Hyperscale Data Center Customer in PJM

Investec-led financing recapitalizes operating assets and funds new construction projects

BOSTON, Nov. 10, 2026 — Calibrant Energy, a leading provider of on-site energy solutions, today announced the close of a $145 million debt facility led by Investec for solar and battery storage projects across multiple U.S. power markets. The portfolio includes a 120 megawatt-hour (MWh) battery energy storage system (BESS) serving a hyperscale data center customer in PJM. Citi, Liberty Bank, and Siemens Financial Services also participated in the facility.

Data center operators are looking for ways to get online faster as PJM and federal regulators work through how large power users connect to the grid. Calibrant’s engineered BESS solutions give energy-intensive facilities greater control over how and when they draw power. This flexibility supports faster interconnection timelines and reduces the need for costly grid infrastructure upgrades that would otherwise be passed on to other ratepayers.

“Data center operators are choosing on-site energy storage because it is a fast, reliable, and effective way to get online and operate as responsible grid citizens,” said Phil Martin, CEO of Calibrant Energy. “With this financial close and site mobilization for a hyperscale data center, Calibrant continues to demonstrate that large-load flexibility is not just possible but a commercial reality today.”

Calibrant’s turnkey, zero-capex solutions unlock the path to reliable power that the world’s largest power users need to grow their businesses.

“Investec is proud to support Calibrant and Macquarie on this transaction,” said Fred Petit, Co-Head of Energy & Infrastructure North America at Investec. “We value the opportunity to partner with experienced investors and operators, and to provide financing that advances the energy transition and the critical infrastructure needed to meet growing power demand across the U.S.”

Calibrant Energy now has more than 5.9 gigawatt-hours (GWh) of battery storage capacity in operation, in construction, or under exclusive development agreements, including additional sites with the same hyperscale customer. This growth reflects rising demand from large power users for on-site energy solutions that accelerate speed to power while easing strain on the grid. It also reflects customers’ preference for a trusted, experienced partner that can develop, own, and operate these solutions and deliver the power outcomes their business plans depend on.

About Calibrant Energy: Calibrant Energy is a leading provider of on-site energy solutions for large power users. Calibrant’s turnkey, zero-capex solutions unlock the paths to power that the world’s largest power users need to grow their businesses, while enabling a more reliable, affordable, and sustainable power grid. As the trusted on-site energy partner to many of the world’s largest enterprises, Calibrant has more than 2.2 GW / 5.9 GWh of projects in operation, construction, or under exclusive development agreements. Calibrant is backed by Macquarie Asset Management. Learn more at www.calibrantenergy.com

About Investec: Investec Bank plc (‘IBP’) is the banking subsidiary of Investec plc. Investec plc is a FTSE 100 listed company which holds the majority of Investec Group’s non-Southern African businesses under a dual listed company structure. IBP partners with private, institutional and corporate clients, offering banking and investment services in the UK, Europe and certain other countries.

IBP also offers wealth management services through its strategic combination with Rathbones Group.  IBP has operated in the UK since 1992. As part of the Investec Group, IBP is a purpose-driven organisation, dedicated to its core purpose of creating enduring worth. This means we will always strive to create long-term value for all stakeholders and contribute meaningfully to people, communities and the planet. Further information can be found at www.investec.com.

SOURCE Calibrant Energy

Broadwing Capital Launches Specialty Distribution Platform with Acquisition of Supply Side

A leader in self-storage and parcel retail, Supply Side serves more than 30,000 businesses across the U.S. and Canada

DALLAS, Nov. 10, 2026 — Broadwing Capital, the Dallas-based private equity firm specializing in the lower middle-market manufacturing and services sectors, today announced its acquisition of Supply Side, the first investment in its new specialty distribution platform. Based in Cleveland, Supply Side distributes packaging materials and hardware, including boxes, tape, bubble wrap, and locks to some of the largest self-storage and parcel shipping operators across the U.S. and Canada.

Supply Side anchors Broadwing’s new platform with a leading position in both self-storage and parcel retail, serving more than 30,000 locations. By designing and stocking the full retail supply display, the company helps its customers operate more securely and efficiently while giving consumers a one-stop shop for moving, storing, and shipping.

“Supply Side brings together the qualities we look for in a platform investment: a strong competitive position in essential, resilient markets, a proven management team, and clear opportunities to grow,” said Eliot Kerlin, Jr., Co-Founder and Managing Partner at Broadwing Capital. “Ansir Junaid has been an outstanding leader for Supply Side, growing the business significantly and building a strong, talented team around him. We’re thrilled to make Supply Side the foundation for our new specialty distribution platform and partner with Junaid and his team on the company’s next phase of growth.”

“We met with a number of private equity firms, and Broadwing stood apart for how much they valued our people and our customers,” said Ansir Junaid, Chief Executive Officer of Supply Side. “Throughout the process, they listened carefully and followed through on every commitment they made. With Broadwing’s strategic depth and discipline behind us, our team is ready to grow Supply Side into new markets and product lines.”

Junaid acquired Supply Side in 2008 after serving the company as a sourcing and logistics partner. Under his leadership, Supply Side significantly grew its self-storage business and built the infrastructure to serve national customers across the U.S. and Canada. He will continue to lead the company as Chief Executive Officer alongside its existing management team and remains an investor in the business.

About Broadwing Capital
Broadwing is a Dallas-based private equity firm specializing in lower middle market manufacturing and services investments. The firm thoughtfully scales niche platforms into market leaders through hands-on operational support that enhances companies, cultures, and communities. Broadwing is known for its founder-friendly approach, experienced team of resource partners, and a values-driven commitment to long-term growth. Since its founding in 2022 by two long-time private equity investors, Broadwing has raised over $730 million of committed capital and closed 26 acquisitions. To learn more, visit our website and follow us on LinkedIn.

About Supply Side
Founded in 1960, Supply Side is a Cleveland-based distributor of packaging materials and hardware for the self-storage and parcel retail industries. The company serves more than 30,000 businesses across the U.S. and Canada, from single storage facilities to regional retail chains and nationwide brands, helping them operate more securely, efficiently, and profitably. Backed by strong supplier partnerships, deep product knowledge, and a commitment to innovation, Supply Side designs and stocks complete retail supply displays that help customers protect their assets, streamline operations, and improve the customer experience. To learn more, visit Supplyside.com.

Media Contact
[email protected] 

SOURCE Broadwing Capital

Mastercraft Ventures Invests in MyoWorks to Help Turn Everyday Chiropractic Tools into Smart, Data-Generating Devices

MyoWorks’ deep musculoskeletal expertise enables the company to tool its physical AI applications to drive measurable productivity and economic gains for care providers

WINDSOR, Wis., Nov. 10, 2026 — MyoWorks, a Wisconsin-based healthcare technology startup, announced today that it has secured an investment from Mastercraft Ventures to develop smart treatment devices for chiropractors, physical therapists, and other musculoskeletal care providers.

MyoWorks’ smart handheld instruments combine multiple treatment methods with software that captures clinical data and automates documentation. The company aims to use this data to track patient progress, inform clinical decisions, and ultimately improve patient outcomes.

“Chiropractic has always been part art and part science, but existing tools capture very little of that knowledge,” said Dr. Jeremy Quick, Founder of MyoWorks. “Mastercraft Ventures’ support enables us to scale our software and physical AI systems, transforming insights into the delivery of treatments and actionable intelligence in the form of a more measurable patient response. This drives greater care efficiencies and will help advance musculoskeletal care for patients worldwide.”

Dr. Quick developed the concept after more than a decade as a practicing chiropractor. By combining treatments traditionally performed separately, he was able to deliver more care during each appointment and increase practice revenue by 20%. He founded MyoWorks to help other practitioners achieve similar results.

MyoWorks is initially targeting the instrument-assisted soft tissue mobilization (IASTM) market, which Mastercraft Ventures estimates includes approximately 135,000 U.S. practitioners. Its technology offers practices the potential to improve both patient care and business performance.

“We believe the next generation of healthcare technology will be driven by practitioner-led insights that connect software and AI directly to the physical tools they use every day,” said Mason Cook, Managing Director of Mastercraft Ventures. “MyoWorks has the potential to

improve practice efficiency while creating an entirely new source of clinical data that enables AI to impact patient outcomes and practitioner efficiencies.”

The investment reflects Mastercraft Ventures’ commitment to backing innovative Wisconsin startups that develop new technologies and create opportunities for economic growth across the state.

“We invest in founders who turn earned insight into innovative, scalable businesses,” Cook added. “Dr. Quick has identified an opportunity to bring intelligence to traditional treatment tools, improving patient care and creating new value for practitioners.”

For more information, visit www.myoworks.us

About Mastercraft Ventures

Mastercraft Ventures is a venture capital fund focused on investing in Wisconsin’s earliest venture-scale founders. Mastercraft Ventures leads equity investment rounds across a broad range of industries, technologies, and products. www.mastercraftvc.com

About MyoWorks

MyoWorks builds smart therapy tools with integrated software for chiropractors, physical therapists, and other musculoskeletal care providers. Its connected tools capture treatment data and generate clinical documentation, helping practitioners improve efficiency, track patient progress, and make more informed clinical decisions. www.myoworks.us

SOURCE MyoWorks

Nanopath Announces $25 Million Series B Financing to Advance Molecular Testing for Women’s Health

Financing co-led by Norwest and SV Health Investors’ MedTech Convergence Fund will fund launch of Nanopath’s FDA 510(k) study for its point-of-care vaginitis test in support of potential expansion of its pipeline into UTIs and STIs, and build-out of its team ahead of proposed commercialization

CAMBRIDGE, Mass., Nov. 10, 2026 — Nanopath, a point-of-care diagnostics company enabling laboratory-quality molecular testing in minutes, today announced the close of a $25 million Series B financing round, which includes $2 million in non-dilutive grant financing. The round is co-led by Norwest and SV Health Investors’ MedTech Convergence Fund, alongside strategic participation from the Labcorp Venture Fund. New and existing investors also participated, including Elderberry Ventures, GingerBread Capital, and Alumni Ventures.

As part of the financing, Catherine Kiani, J.D., Managing Partner at Elderberry Ventures, and Mindy Nye, Ph.D., Vice President, Labcorp Diagnostics, have joined the Nanopath Board as Observers.

“Nanopath is developing truly transformative technology with the potential to reshape the molecular diagnostics industry and dramatically improve patient outcomes,” said Jeff Crowe, Senior Managing Partner at Norwest. “We are beyond excited to continue supporting the company at this key inflection point.”

Nanopath has developed the first clinical diagnostics platform built on plasmonic biosensing. The company’s proprietary optical biosensing technology is designed to enable molecular detection without nucleic acid amplification, a step required by PCR-based tests. “We’ve spent years developing and pressure-testing a fundamentally new approach to molecular diagnostics for patients who have been overlooked for far too long,” said Alison Burklund, Ph.D., Co-Founder & Co-CEO of Nanopath. “This funding brings us closer to the next and most important step – translating that innovation into meaningful clinical impact.”

The funding will support key milestones toward the potential commercial launch of Nanopath’s 15-minute point-of-care vaginitis assay, including manufacturing scale-up and initiation of Nanopath’s Food and Drug Administration 510(k) clinical study. Nanopath will also use the funding to expand its team across clinical and commercial functions as it prepares for launch. “We’re incredibly proud of the extraordinary team we’ve built at Nanopath and our shared commitment to transforming women’s healthcare,” said Amogha Tadimety, Ph.D., Co-Founder & Co-CEO of Nanopath. “We’re grateful for the confidence of our investors and excited to build on this momentum as we enter our next phase of growth.”

By delivering accurate results during a single visit, Nanopath aims to establish a new standard of care for women’s health and expand access to high-quality diagnostics for women across the United States. Over time, the platform is expected to expand to other clinical indications, improving healthcare by making sophisticated diagnostics more accessible at the point of care.

The vaginitis test is currently under development and has not been cleared or approved by the U.S. Food and Drug Administration. Commercial availability is subject to successful completion of development activities and applicable regulatory review.

About Nanopath
Nanopath is a women-led company dedicated to improving health equity worldwide, starting with women’s health. Nanopath’s proprietary molecular diagnostic testing platform takes a radically new approach to how clinicians characterize human health. The company’s novel biosensing technology has the potential to enable fast, high-complexity testing at the point-of-care, rather than in centralized laboratories. The company is headquartered in Cambridge, Mass., at The Engine built by MIT, a premier facility for high-potential, tough-tech start-ups. Founded in 2020, Nanopath has raised more than $46 million, and is backed by Norwest, the Medtech Convergence Fund, an SV Health Investors Fund, Elderberry Ventures, GingerBread Capital, Alumni Ventures and the Labcorp Venture Fund. For more information, visit www.nanopath.com.

SOURCE Nanopath